89 related articles for article (PubMed ID: 22349825)
21. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
Fields AP; Frederick LA; Regala RP
Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma.
Kikuchi K; Soundararajan A; Zarzabal LA; Weems CR; Nelon LD; Hampton ST; Michalek JE; Rubin BP; Fields AP; Keller C
Oncogene; 2013 Jan; 32(3):286-95. PubMed ID: 22349825
[TBL] [Abstract][Full Text] [Related]
23. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
[TBL] [Abstract][Full Text] [Related]
24. Atypical protein kinase C iota expression and aurothiomalate sensitivity in human lung cancer cells.
Regala RP; Thompson EA; Fields AP
Cancer Res; 2008 Jul; 68(14):5888-95. PubMed ID: 18632643
[TBL] [Abstract][Full Text] [Related]
25. Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ciota.
Erdogan E; Lamark T; Stallings-Mann M; Lee Jamieson ; Pellecchia M; Thompson EA; Johansen T; Fields AP
J Biol Chem; 2006 Sep; 281(38):28450-9. PubMed ID: 16861740
[TBL] [Abstract][Full Text] [Related]
26. A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells.
Stallings-Mann M; Jamieson L; Regala RP; Weems C; Murray NR; Fields AP
Cancer Res; 2006 Feb; 66(3):1767-74. PubMed ID: 16452237
[TBL] [Abstract][Full Text] [Related]
27. Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma.
Rubin BP; Nishijo K; Chen HI; Yi X; Schuetze DP; Pal R; Prajapati SI; Abraham J; Arenkiel BR; Chen QR; Davis S; McCleish AT; Capecchi MR; Michalek JE; Zarzabal LA; Khan J; Yu Z; Parham DM; Barr FG; Meltzer PS; Chen Y; Keller C
Cancer Cell; 2011 Feb; 19(2):177-91. PubMed ID: 21316601
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
Murray NR; Kalari KR; Fields AP
J Cell Physiol; 2011 Apr; 226(4):879-87. PubMed ID: 20945390
[TBL] [Abstract][Full Text] [Related]
29. Tiam1-Rac signaling counteracts Eg5 during bipolar spindle assembly to facilitate chromosome congression.
Woodcock SA; Rushton HJ; Castañeda-Saucedo E; Myant K; White GR; Blyth K; Sansom OJ; Malliri A
Curr Biol; 2010 Apr; 20(7):669-75. PubMed ID: 20346677
[TBL] [Abstract][Full Text] [Related]
30. Targets for cancer therapy in childhood sarcomas.
Wachtel M; Schäfer BW
Cancer Treat Rev; 2010 Jun; 36(4):318-27. PubMed ID: 20223596
[TBL] [Abstract][Full Text] [Related]
31. Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis.
Scotti ML; Bamlet WR; Smyrk TC; Fields AP; Murray NR
Cancer Res; 2010 Mar; 70(5):2064-74. PubMed ID: 20179210
[TBL] [Abstract][Full Text] [Related]
32. Protection from rapamycin-induced apoptosis by insulin-like growth factor-I is partially dependent on protein kinase C signaling.
Thimmaiah KN; Easton JB; Houghton PJ
Cancer Res; 2010 Mar; 70(5):2000-9. PubMed ID: 20179209
[TBL] [Abstract][Full Text] [Related]
33. aPKClambda/iota promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6.
Ishiguro H; Akimoto K; Nagashima Y; Kojima Y; Sasaki T; Ishiguro-Imagawa Y; Nakaigawa N; Ohno S; Kubota Y; Uemura H
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16369-74. PubMed ID: 19805306
[TBL] [Abstract][Full Text] [Related]
34. Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis.
Regala RP; Davis RK; Kunz A; Khoor A; Leitges M; Fields AP
Cancer Res; 2009 Oct; 69(19):7603-11. PubMed ID: 19738040
[TBL] [Abstract][Full Text] [Related]
35. Rhabdomyosarcoma in children.
Hayes-Jordan A; Andrassy R
Curr Opin Pediatr; 2009 Jun; 21(3):373-8. PubMed ID: 19448544
[TBL] [Abstract][Full Text] [Related]
36. Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma.
Nishijo K; Chen QR; Zhang L; McCleish AT; Rodriguez A; Cho MJ; Prajapati SI; Gelfond JA; Chisholm GB; Michalek JE; Aronow BJ; Barr FG; Randall RL; Ladanyi M; Qualman SJ; Rubin BP; LeGallo RD; Wang C; Khan J; Keller C
Cancer Res; 2009 Apr; 69(7):2902-11. PubMed ID: 19339268
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
